During the past decade, Investigative Clinical Research Of Indiana, Llc conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 22 clinical trials were completed, i.e. on average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Investigative Clinical Research Of Indiana, Llc" #1 sponsor was "Bristol-Myers Squibb" with 9 trials, followed by "Celgene" with 4 trials sponsored, "Millennium Pharmaceuticals, Inc." with 3 trials sponsored, "Pharmacyclics LLC." with 3 trials sponsored and "AVEO Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Investigative Clinical Research Of Indiana, Llc" #1 collaborator was "AbbVie" with 5 trials as a collaborator, "Amgen" with 2 trials as a collaborator, "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 2 trials as a collaborator, "Celgene" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Investigative Clinical Research Of Indiana, Llc" are "Multiple Myeloma" (8 trials), "Pancreatic Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Melanoma" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Investigative Clinical Research Of Indiana, Llc" in a lesser frequency.

Most popular intervention types in "Investigative Clinical Research Of Indiana, Llc" are "Drug" (36 trials), "Biological" (12 trials), "Other" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (7 trials), "Bortezomib" (4 trials), "Elotuzumab" (4 trials), "Gemcitabine" (4 trials) and "Nivolumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Investigative Clinical Research Of Indiana, Llc" are 42 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Investigative Clinical Research Of Indiana, Llc". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Investigative Clinical Research Of Indiana, Llc, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Investigative Clinical Research Of Indiana, Llc, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".